Unlocking the Power of the Mind: A deep dive into global mental wellness strategies, interventions, and innovations suggest that the market is anticipated to cross USD 370 Billion by 2029.
Lifescience
The Global Anti-Snoring Device market provides a variety of solutions for individuals who suffer from snoring, sleep apnea, or related sleep disorders, allowing them to improve their quality of life and maintain good health. – Bonafide Research
Snoring is characterized as a vibration of the resiratory tract due to obstruction in the airway flow. Snoring is caused by a variety of factors, including airway obstruction, sleep apnea; sleep deprivation, obesity, and mouth breathing. Sedentism has increased the prevalence of sleep deprivation and obesity, among other things. The rising prevalence of sleep apnea among the elderly globally is expected to drive the market in the coming years. Furthermore, rising smoking and alcohol consumption, rising prevalence of sleep apnea, technological advancements in the market pertaining to anti-snoring devices, product launches and approvals, and others are providing significant opportunities for market growth. As a result, the market for anti-snoring devices is expanding. Besides, chronic snoring increases the risk of fatigue, heart attacks, hypertension, stroke, type 2 diabetes, and low blood oxygen levels. Aside from that, loud and frequent snoring is one of the symptoms of sleep apnea, a chronic condition marked by shallow breaths or pauses in breathing while sleeping. Glaucoma, cancer, and cognitive and behavioral disorders can all result from this condition. Moreover, people with sleep apnea are more likely to be involved in a car accident as it may impair driving fitness.
According to Bonafide Research's research report, "Global Anti- Snoring Device Market Outlook, 2028," the global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022. An increase in tobacco and alcohol consumption, as well as increased awareness of the negative consequences of snoring caused by these factors, are driving the market. Throughout the forecast period, technological advancements in the market will drive the global anti-snoring device market. Furthermore, low-cost and minimally invasive devices, combined with associated product benefits, may drive demand. Additionally, the rising prevalence of obesity, diabetes, and other chronic diseases has an effect. Furthermore, an increase in the geriatric population base susceptible to obesity boosts demand for anti-snoring products. The growing patient preference for anti-snoring devices will drive demand for such devices, propelling the anti-snoring device market forward. Furthermore, rising snoring awareness, increased disposable income, and advanced product development will drive demand for anti-snoring devices in the coming years. Wearable anti-snoring devices are becoming increasingly popular as they offer a non-invasive and convenient solution for snoring and sleep apnea. These devices typically come in the form of a mouthguard or nasal device that is worn during sleep. Furthermore, Anti-snoring pillows have gained popularity in recent years as a non-invasive and comfortable solution for snoring and sleep apnea. These pillows are designed to encourage proper sleep posture and help keep the airways open during sleep.
Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the Global market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy.
The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in global, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices.
For instance, according to World Health Organization (WHO) data published in 2021, an estimated 38.2 million children under the age of five were overweight or obese in 2019. Furthermore, the source concluded that nearly half of the children under the age of five who were overweight or obese in 2019 lived in Asia. Obesity increases the likelihood of snoring and obstructive sleep apnea because neck fat compresses the upper airway, especially when lying down, making snoring much more likely. Furthermore, central obesity, defined as fat around the midriff and chest, exacerbates snoring and sleep apnea. Obesity will thus increase the prevalence of obstructive sleep apnea and snoring, resulting in a greater demand for snoring management and treatment devices in the coming years.
Furthermore, the growing geriatric population around the world will help propel the market for anti-snoring devices during the study period (2022 – 2027). According to WHO 2022, in 2020, the number of people aged 60 and up outnumbered children under the age of five worldwide. According to the data provided by the aforementioned source, one in every six people in the world will be 60 or older by 2030. At this time, the proportion of the global population aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion in 2030. Furthermore, the world's population of people aged 60 and up will nearly double to 2.1 billion by 2050. The same source also provided the number of people aged 80 and up, which is expected to triple between 2020 and 2050 to reach 426 million globally. Geriatric people are more prone to snoring and sleep apnea due to the apparent weakening and loss of tone of upper airway muscles during sleep, which predisposes to airway obstruction and snoring.
Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2021. According to the most recent data from the National Center for Biotechnology Information, 1 in every 15 people in the United States has moderate to severe symptoms of a sleep disorder. According to the latest Associated Professional Sleep Societies study, obstructive sleep apnea (OSA) may affect up to 37% of adults in North, Central, and South America. Furthermore, according to the Centers for Disease Control and Prevention, all states and territories in the United States have an obesity rate of at least 20% in 2019. According to the source, approximately 18.5% of children aged 2 to 19 in the United States were obese in 2019. Obesity among the people in the region will increase the demand for anti-snoring devices because obese and overweight people are more prone to snoring due to the presence of excessive fat accumulation near the neck or chest, which may cause narrowing of airways, causing snoring, ultimately leading to an increase in demand for snoring management and treatment devices, propelling the overall market of anti-snoring devices in North America during 2023 - 2028.
Some of the recent product launches include the new anti-snoring device called the Oventus Clearway, which has a unique design that directs air through a small opening in the mouthpiece and is effective in reducing snoring and improving sleep quality in people with obstructive sleep apnea. Furthermore, the FDA issued a warning about certain anti-snoring devices that use magnets, stating that they can cause serious injuries such as tissue damage, broken teeth, and choking if swallowed. The FDA recommended that people stop using these devices and seek alternative treatments for snoring. Moreover, a new study presented at the European Respiratory Society International Congress found that a new type of anti-snoring device called the NightOwl, which uses a small balloon to inflate and support the nasal passages, was effective in reducing snoring and improving sleep quality in people with snoring and mild to moderate obstructive sleep apnea. In addition, a new anti-snoring device called the SmartSnore, which uses a combination of positional therapy and vibration therapy to reduce snoring, was launched in the UK. The device is worn on the chest and vibrates when the wearer rolls onto their back during sleep, encouraging them to shift to a side-sleeping position.
There are several groups and organizations that promote the use of anti-snoring devices and provide education and support for people with snoring and sleep apnea around the world. Some of the organizations include ESADA, a research initiative that collects data on sleep apnea and related conditions across Europe, including information on the use of anti-snoring devices. Furthermore, the CSS is a professional organization for sleep researchers and clinicians in Canada that provides information and resources on sleep disorders, including snoring and sleep apnea. Moreover, the NSF is a non-profit organization that promotes healthy sleep habits and provides education and support for people with sleep disorders. They offer information on a variety of topics related to sleep, including anti-snoring devices. In addition, the APSSM is a professional organization for sleep researchers and clinicians in the Asia-Pacific region. They offer education and resources for people with sleep disorders, including information on anti-snoring devices and other treatments.
According to Bonafide Research's research report, "Global Anti- Snoring Device Market Outlook, 2028," the global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022. An increase in tobacco and alcohol consumption, as well as increased awareness of the negative consequences of snoring caused by these factors, are driving the market. Throughout the forecast period, technological advancements in the market will drive the global anti-snoring device market. Furthermore, low-cost and minimally invasive devices, combined with associated product benefits, may drive demand. Additionally, the rising prevalence of obesity, diabetes, and other chronic diseases has an effect. Furthermore, an increase in the geriatric population base susceptible to obesity boosts demand for anti-snoring products. The growing patient preference for anti-snoring devices will drive demand for such devices, propelling the anti-snoring device market forward. Furthermore, rising snoring awareness, increased disposable income, and advanced product development will drive demand for anti-snoring devices in the coming years. Wearable anti-snoring devices are becoming increasingly popular as they offer a non-invasive and convenient solution for snoring and sleep apnea. These devices typically come in the form of a mouthguard or nasal device that is worn during sleep. Furthermore, Anti-snoring pillows have gained popularity in recent years as a non-invasive and comfortable solution for snoring and sleep apnea. These pillows are designed to encourage proper sleep posture and help keep the airways open during sleep.
Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the Global market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy.
The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in global, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices.
For instance, according to World Health Organization (WHO) data published in 2021, an estimated 38.2 million children under the age of five were overweight or obese in 2019. Furthermore, the source concluded that nearly half of the children under the age of five who were overweight or obese in 2019 lived in Asia. Obesity increases the likelihood of snoring and obstructive sleep apnea because neck fat compresses the upper airway, especially when lying down, making snoring much more likely. Furthermore, central obesity, defined as fat around the midriff and chest, exacerbates snoring and sleep apnea. Obesity will thus increase the prevalence of obstructive sleep apnea and snoring, resulting in a greater demand for snoring management and treatment devices in the coming years.
Furthermore, the growing geriatric population around the world will help propel the market for anti-snoring devices during the study period (2022 – 2027). According to WHO 2022, in 2020, the number of people aged 60 and up outnumbered children under the age of five worldwide. According to the data provided by the aforementioned source, one in every six people in the world will be 60 or older by 2030. At this time, the proportion of the global population aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion in 2030. Furthermore, the world's population of people aged 60 and up will nearly double to 2.1 billion by 2050. The same source also provided the number of people aged 80 and up, which is expected to triple between 2020 and 2050 to reach 426 million globally. Geriatric people are more prone to snoring and sleep apnea due to the apparent weakening and loss of tone of upper airway muscles during sleep, which predisposes to airway obstruction and snoring.
Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2021. According to the most recent data from the National Center for Biotechnology Information, 1 in every 15 people in the United States has moderate to severe symptoms of a sleep disorder. According to the latest Associated Professional Sleep Societies study, obstructive sleep apnea (OSA) may affect up to 37% of adults in North, Central, and South America. Furthermore, according to the Centers for Disease Control and Prevention, all states and territories in the United States have an obesity rate of at least 20% in 2019. According to the source, approximately 18.5% of children aged 2 to 19 in the United States were obese in 2019. Obesity among the people in the region will increase the demand for anti-snoring devices because obese and overweight people are more prone to snoring due to the presence of excessive fat accumulation near the neck or chest, which may cause narrowing of airways, causing snoring, ultimately leading to an increase in demand for snoring management and treatment devices, propelling the overall market of anti-snoring devices in North America during 2023 - 2028.
Some of the recent product launches include the new anti-snoring device called the Oventus Clearway, which has a unique design that directs air through a small opening in the mouthpiece and is effective in reducing snoring and improving sleep quality in people with obstructive sleep apnea. Furthermore, the FDA issued a warning about certain anti-snoring devices that use magnets, stating that they can cause serious injuries such as tissue damage, broken teeth, and choking if swallowed. The FDA recommended that people stop using these devices and seek alternative treatments for snoring. Moreover, a new study presented at the European Respiratory Society International Congress found that a new type of anti-snoring device called the NightOwl, which uses a small balloon to inflate and support the nasal passages, was effective in reducing snoring and improving sleep quality in people with snoring and mild to moderate obstructive sleep apnea. In addition, a new anti-snoring device called the SmartSnore, which uses a combination of positional therapy and vibration therapy to reduce snoring, was launched in the UK. The device is worn on the chest and vibrates when the wearer rolls onto their back during sleep, encouraging them to shift to a side-sleeping position.
There are several groups and organizations that promote the use of anti-snoring devices and provide education and support for people with snoring and sleep apnea around the world. Some of the organizations include ESADA, a research initiative that collects data on sleep apnea and related conditions across Europe, including information on the use of anti-snoring devices. Furthermore, the CSS is a professional organization for sleep researchers and clinicians in Canada that provides information and resources on sleep disorders, including snoring and sleep apnea. Moreover, the NSF is a non-profit organization that promotes healthy sleep habits and provides education and support for people with sleep disorders. They offer information on a variety of topics related to sleep, including anti-snoring devices. In addition, the APSSM is a professional organization for sleep researchers and clinicians in the Asia-Pacific region. They offer education and resources for people with sleep disorders, including information on anti-snoring devices and other treatments.
Related Press Releases
Quick Contacts
Trusted Partners
Latest Press Release
We are friendly and approachable, give us a call.